Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor

被引:14
|
作者
Bertini, Simone [1 ]
Chicca, Andrea [2 ]
Gado, Francesca [1 ]
Arena, Chiara [1 ]
Nieri, Daniela [2 ]
Digiacomo, Maria [1 ]
Saccomanni, Giuseppe [1 ]
Zhao, Pingwei [3 ]
Abood, Mary E. [3 ]
Macchia, Marco [1 ]
Gertsch, Jurg [2 ]
Manera, Clementina [1 ]
机构
[1] Univ Pisa, Dept Pharm, I-56126 Pisa, Italy
[2] Univ Bern, NCCR TransCure, Inst Biochem & Mol Med, Buhlstr 28, CH-3012 Bern, Switzerland
[3] Temple Univ, Lewis Katz Sch Med, Ctr Subst Abuse Res, Philadelphia, PA 19140 USA
关键词
Allosteric modulator; CB1; receptor; Endocannabinoid system; MAPK/ERK signaling pathway; Serum response element; ENDOCANNABINOID SYSTEM; HUMAN HEALTH; PHARMACOLOGY; STRATEGIES; AGONISTS; PAIN;
D O I
10.1016/j.bmc.2017.10.015
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In this work, we explored the molecular framework of the known CB1R allosteric modulator PSNCBAM-1 with the aim to generate new bioactive analogs and to deepen the structure-activity relationships of this type of compounds. In particular, the introduction of a NH group between the pyridine ring and the phenyl nucleus generated the amino-phenyl-urea derivative SN15b that behaved as a positive allosteric modulator (PAM), increasing the CB1R binding affinity of the orthosteric ligand CP55,940. The functional activity was evaluated using serum response element (SRE) assay, which assesses the CB1R-dependent activation of the MAPK/ERK signaling pathway. SN15b and the biphenyl-urea analog SC4a significantly inhibited the response produced by CP55,940 in the low mu M range, thus behaving as negative allosteric modulators (NAMs). The new derivatives presented here provide further insights about the modulation of CB1R binding and functional activity by allosteric ligands. (C) 2017 Elsevier Ltd. All rights reserved.
引用
下载
收藏
页码:6427 / 6434
页数:8
相关论文
共 50 条
  • [1] PSNCBAM-1 analogs: Structural evolutions and allosteric properties at cannabinoid CB1 receptor
    Meini, Serena
    Gado, Francesca
    Stevenson, Lesley A.
    Digiacomo, Maria
    Saba, Alessandro
    Codini, Simone
    Macchia, Marco
    Pertwee, Roger G.
    Bertini, Simone
    Manera, Clementina
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 203
  • [2] PSNCBAM-1, a novel allosteric antagonist at cannabinoid CB1 receptors with hypophagic effects in rats
    Horswill, J. G.
    Bali, U.
    Shaaban, S.
    Keily, J. F.
    Jeevaratnam, P.
    Babbs, A. J.
    Reynet, C.
    In, P. Wong Kai
    BRITISH JOURNAL OF PHARMACOLOGY, 2007, 152 (05) : 805 - 814
  • [3] Structural Optimization of the Diarylurea PSNCBAM-1, an Allosteric Modulator of Cannabinoid Receptor 1
    Dopart, Rachel
    Immadi, Sri Sujana
    Lu, Dai
    Kendall, Debra A.
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2020, 92
  • [4] Rational design of cannabinoid type-1 receptor allosteric modulators: Org27569 and PSNCBAM-1 hybrids
    Nguyen, Thuy
    Gamage, Thomas F.
    Decker, Ann M.
    Finlay, David B.
    Langston, Tiffany L.
    Barrus, Daniel
    Glass, Michelle
    Harris, Danni L.
    Zhang, Yanan
    BIOORGANIC & MEDICINAL CHEMISTRY, 2021, 41
  • [5] Novel positive allosteric modulators of CB1 cannabinoid receptor for the treatment of anorexia nervosa
    Kulkarni, Pushkar M.
    Jarbe, Torbjorn
    Goldberg, Steven
    Barbarich-Marsteller, Nicole R.
    Thakur, Ganesh A.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2013, 246
  • [6] Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor
    Lu, Dai
    Immadi, Sri Sujana
    Wu, Zhixing
    Kendall, Debra A.
    ACTA PHARMACOLOGICA SINICA, 2019, 40 (03) : 324 - 335
  • [7] Allosteric Modulators of the CB1 Cannabinoid Receptor: A Structural Update Review
    Morales, Paula
    Goya, Pilar
    Jagerovic, Nadine
    Hernandez-Folgado, Laura
    CANNABIS AND CANNABINOID RESEARCH, 2016, 1 (01) : 22 - 30
  • [8] Translational potential of allosteric modulators targeting the cannabinoid CB1 receptor
    Dai Lu
    Sri Sujana Immadi
    Zhixing Wu
    Debra A. Kendall
    Acta Pharmacologica Sinica, 2019, 40 : 324 - 335
  • [9] Preclinical Evaluation of Neutral Cannabinoid CB1 Receptor Antagonists and Cannabinoid CB1 Receptor Negative Allosteric Modulators for Treating Drug Addiction
    Gardner, Eliot L.
    Bi, Guo-Hua
    Thakur, Ganesh
    Makriyannis, Alexandros
    Seltzman, Herbert H.
    He, Xiang-Hu
    Xi, Zheng-Xiong
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 152 - 152
  • [10] Allosteric Modulation of Cannabinoid CB1 Receptor
    Ross, Ruth A.
    Baillie, Gemma L.
    Pertwee, Roger G.
    FASEB JOURNAL, 2012, 26